Global $18.3 Billion Wearable Injectors Markets, 2021-2028

Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Wearable Injectors Market Size, Share & Trends Analysis Report by Type (On-body, Off-body), by Technology (Spring-based, Motor-driven), by Application (Oncology, Autoimmune Diseases), by End Use, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global wearable injectors market size is expected to reach USD 18.3 billion by 2028. It is expected to expand at a CAGR of 17.2% from 2021 to 2028.

Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.

Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.

The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term.

Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.

Wearable Injectors Market Report Highlights

• By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin.

• The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes.

• The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic.

• North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases.

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Wearable Injectors Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Industry challenges
3.4. Wearable Injectors Market Analysis Tools
3.4.1. Industry Analysis-Porter's
3.4.2. PESTEL Analysis
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies

Chapter 4. Wearable Injectors Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Definitions and Scope
4.3. Wearable Injectors Market Share, 2020 & 2028
4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.4.1. On-body
4.4.2. Off-body

Chapter 5. Wearable Injectors Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Definitions and Scope
5.3. Wearable Injectors Market Share, 2020 & 2028
5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.4.1. Spring-based
5.4.2. Motor-driven
5.4.3. Rotary Pump
5.4.4. Expanding Battery
5.4.5. Others

Chapter 6. Wearable Injectors Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Definitions and Scope
6.3. Wearable Injectors Market Share, 2020 & 2028
6.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.4.1. Oncology
6.4.2. Infectious Diseases
6.4.3. Cardiovascular Diseases
6.4.4. Autoimmune Diseases
6.4.5. Others

Chapter 7. Wearable Injectors Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Definitions and Scope
7.3. Wearable Injectors Market Share, 2020 & 2028
7.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Home Care
7.4.4. Others

Chapter 8. Wearable Injectors: Regional Estimates & Trend Analysis
8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2020 & 2028
8.3. Regional Market Share, 2020

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.1.1. Company overview
9.1.2. Financial performance
9.1.3. Product benchmarking
9.1.4. Strategic initiatives

• Becton, Dickinson and Company

• Johnson & Johnson Services, Inc.

• F. Hoffmann-La Roche Ltd.

• Unilife Corporation

• SteadyMed Therapeutics, Inc.

• Amgen Inc.

• Insulet Corporation

• Enable Injections

• West Pharmaceutical Services, Inc.

• CeQur SA

For more information about this report visit https://www.researchandmarkets.com/r/b3ts7w

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900